We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Dangerous pathogens need tighter security to prevent theft, accidents or terrorism
Move is part of bloc’s effort to boost faltering immunisation programme
After suffering a breakdown, the acclaimed writer has found hope in new therapies
Emergency use authorisation could help identify ‘long Covid’ sufferers
Government decision to defy calls for phased restart unnerves families, and teachers, despite stress of home schooling
Twelve months on from Europe’s first coronavirus lockdown, restrictions still dominate life in Italian city
Italy’s export block of Oxford/AstraZeneca jabs to Australia comes amid discontent over EU policy
Health secretary Matt Hancock praises NHS test and trace for ‘dogged determination’ in tracking individual down
Canberra urges Brussels to review Rome’s move while also expressing sympathy to EU
Three east London boroughs were already at breaking point. Then the pandemic struck
There is something powerful about the idea that until the lockdowns can be eased for everyone, they should be eased for nobody
U-turn could help speed up the country’s sluggish Covid-19 vaccination campaign
Intervention threatens to increase global tensions over procurement of Covid jabs
Pace of lay-offs remains stubbornly high despite some easing of coronavirus curbs
Decision makes approval possible in as little as two weeks after final data is received from manufacturers
German airline group flew 76% fewer passengers in 2020 and is burning €300m per month
Governments divided over merits of pandemic passports as non-EU vaccines administered in the bloc
WHO-backed report concludes that 9 out of 10 fatalities have occurred in countries with high obesity levels
Buyout group’s approach comes as private equity makes a push for healthcare deals amid pandemic
Criminal gangs seek to capitalise on global demand for coronavirus jabs
US study likely to alleviate some concerns about new strains outsmarting vaccines
The more we destabilise the planet in the name of advancement, the more pathogens will emerge
International Edition
